START domain protein structure and ligand specificity

Cholesterol Transporters of the START Domain Protein Family in Health and Disease: START Proteins-Structure and Function

Volumn , Issue , 2014, Pages 49-72

  Danny, Danny Létourneau ^a   Lavigne, Pierre ^a   Lefebvre, Andrée ^a   Lehoux, Jean Guy ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Bile acids; Binding mechanism; Cholesterol; Lipids; Nuclear magnetic resonance (NMR) spectroscopy; START domains; Structure; Thermodynamics

Indexed keywords

EID: 84948118234     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1112-7_3     Document Type: Chapter

References (95)

1. Lehoux JG, Sandor T, Henderson IW, Jones IC. Some aspects of the dietary sodium intake on the regulation of aldosterone biosynthesis in rat adrenals. Can J Biochem. 1974 Jan;52(1):1–6.
2. LeHoux J-G, Bernard H, Ducharme L, Lefebvre A, Shapcott D, Tremblay A, et al. The regulation of the formation of glucocorticoids and mineralocorticoids in vivo. In: Bittar EE, editor. Advances in molecular and cell biology. Elsevier: London; 1996. pp. 149–201.
3. Karaboyas GC, Koritz SB. Identity of the site of action of 3′,5′-adenosine monophosphate and adrenocortocotropic hormone in corticosteroidogenesis in rat adrenal and beef adrenal cortex slices. Biochemistry. 1965 March 1;4(3):462–8.
4. Stone D, Hechter O. Studies on ACTH action in perfused bovine adrenals: the site of action of ACTH in corticosteroidogenesis. Arch Biochem Biophys. 1954 Aug;51(2):457–69.
5. Privalle CT, Crivello JF, Jefcoate CR. Regulation of intramitochondrial cholesterol transfer to side-chain cleavage cytochrome P-450 in rat adrenal gland. Proc Natl Acad Sci USA. 1983 Feb;80(3):702–6.
6. Yago N, Ichii S. Submitochondrial distribution of components of the steroid 11 beta-hydroxylase and cholesterol sidechain-cleaving enzyme systems in hog adrenal cortex. J Biochem. 1969 Feb;65(2):215–24.
7. Arthur JR, Boyd GS. The effect of inhibitors of protein synthesis on cholesterol sidechain cleavage in the mitochondria of luteinized rat ovaries. Eur J Biochem. 1974 Nov 1;49(1):117–27.
8. Epstein LF, Orme-Johnson NR. Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J Biol Chem. 1991 Oct 15;266(29):19739–45.
9. Krueger RJ, Orme-Johnson NR. Acute adrenocorticotropic hormone stimulation of adrenal corticosteroidogenesis. Discovery of a rapidly induced protein. J Biol Chem. 1983 Aug 25;258(16):10159–67.
10. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994 Nov 11;269(45):28314–22.
11. Lin D, Sugawara T, Strauss JF, 3rd, Clark BJ, Stocco DM, Saenger P, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 1995 March 24;267(5205):1828–31.
12. Fleury A, Ducharme L, LeHoux JG. In vivo effects of adrenocorticotrophin on the expression of the hamster steroidogenic acute regulatory protein. J Mol Endocrinol. 1998 Oct;21(2): 131–9.
13. Lehoux JG, Hales DB, Fleury A, Briere N, Martel D, Ducharme L. The in vivo effects of adrenocorticotropin and sodium restriction on the formation of the different species of steroidogenic acute regulatory protein in rat adrenal. Endocrinology. 1999 Nov;140(11):5154–64.
14. Fleury A, Mathieu AP, Ducharme L, Hales DB, LeHoux JG. Phosphorylation and function of the hamster adrenal steroidogenic acute regulatory protein (StAR). J Steroid Biochem Mol Biol. 2004 Aug;91(4–5):259–71.
15. Mathieu AP, Fleury A, Ducharme L, Lavigne P, LeHoux JG. Insights into steroidogenic acute regulatory protein (StAR)-dependent cholesterol transfer in mitochondria: evidence from molecular modeling and structure-based thermodynamics supporting the existence of partially unfolded states of StAR. J Mol Endocrinol. 2002 Dec;29(3):327–45.
16. Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol. 2000 May;7(5):408–14.
17. Thorsell AG, Lee WH, Persson C, Siponen MI, Nilsson M, Busam RD, et al. Comparative structural analysis of lipid binding START domains. PLoS One. 2011;6(6):e19521.
18. Murcia M, Faraldo-Gomez JD, Maxfield FR, Roux B. Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol. J Lipid Res. 2006 Dec;47(12):2614–30.
19. Iyer LM, Koonin EV, Aravind L. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins. 2001 May 1;43(2):134–44.
20. Schrick K, Nguyen D, Karlowski WM, Mayer KF. START lipid/sterol-binding domains are amplified in plants and are predominantly associated with homeodomain transcription factors. Genome Biol. 2004;5(6):R41.
21. Mathieu AP, Lavigne P, LeHoux JG. Molecular modeling and structure-based thermodynamic analysis of the StAR protein. Endocr Res. 2002 Nov;28(4):419–23.
22. Ponting CP, Aravind L. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem Sci. 1999 April;24(4):130–2.
23. Alpy F, Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci. 2005 July 1;118(Pt 13):2791–801.
24. Clark BJ. The mammalian START domain protein family in lipid transport in health and disease. J Endocrinol. 2012 March;212(3):257–75.
25. Bhangoo A, Gu WX, Pavlakis S, Anhalt H, Heier L, Ten S, et al. Phenotypic features associated with mutations in steroidogenic acute regulatory protein. J Clin Endocrinol Metab. 2005 Nov;90(11):6303–9.
26. Bose HS, Sugawara T, Strauss JF, 3rd, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med. 1996 Dec 19;335(25):1870–8.
27. Chen X, Baker BY, Abduljabbar MA, Miller WL. A genetic isolate of congenital lipoid adrenal hyperplasia with atypical clinical findings. J Clin Endocrinol Metab. 2005 Feb;90(2):835–40.
28. Fluck CE, Pandey AV, Dick B, Camats N, Fernandez-Cancio M, Clemente M, et al. Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing nonclassic lipoid adrenal hyperplasia. PLoS One. 2011;6(5):e20178.
29. Gassner HL, Toppari J, Quinteiro Gonzalez S, Miller WL. Near-miss apparent SIDS from adrenal crisis. J Pediatr. 2004 Aug;145(2):178–83.
30. Katsumata N, Kawada Y, Yamamoto Y, Noda M, Nimura A, Horikawa R, et al. A novel compound heterozygous mutation in the steroidogenic acute regulatory protein gene in a patient with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab. 1999 Nov;84(11): 3983–7.
31. Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstol K, et al. Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia. Acta Obstet Gynecol Scand. 2009;88(2):222–6.
32. Lavigne P, Najmanivich R, Lehoux JG. Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding. Subcell Biochem. 2010;51:425–37.
33. Lehoux JG, Mathieu A, Lavigne P, Fleury A. Adrenocorticotropin regulation of steroidogenic acute regulatory protein. Microsc Res Tech. 2003 June 15;61(3):288–99.
34. Nakae J, Tajima T, Sugawara T, Arakane F, Hanaki K, Hotsubo T, et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet. 1997 April;6(4):571–6.
35. Alpy F, Tomasetto C. MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem Soc Trans. 2006 June;34(Pt 3):343–5.
36. Soccio RE, Adams RM, Romanowski MJ, Sehayek E, Burley SK, Breslow JL. The cholesterol- regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc Natl Acad Sci USA. 2002 May 14;99(10):6943–8.
37. Rodriguez-Agudo D, Ren S, Hylemon PB, Redford K, Natarajan R, Del Castillo A, et al. Human StarD5, a cytosolic StAR-related lipid binding protein. J Lipid Res. 2005 Aug;46(8):1615–23.
38. Rodriguez-Agudo D, Ren S, Wong E, Marques D, Redford K, Gil G, et al. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J Lipid Res. 2008 July;49(7):1409–19.
39. Elbadawy HM, Borthwick F, Wright C, Martin PE, Graham A. Cytosolic StAR-related lipid transfer domain 4 (STARD4) protein influences keratinocyte lipid phenotype and differentiation status. Br J Dermatol. 2011 March;164(3):628–32.
40. Rodriguez-Agudo D, Calderon-Dominguez M, Ren S, Marques D, Redford K, Medina-Torres MA, et al. Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim Biophys Acta. 2011 Oct;1811(10):597–606.
41. Rodriguez-Agudo D, Ren S, Hylemon PB, Montanez R, Redford K, Natarajan R, et al. Localization of StarD5 cholesterol binding protein. J Lipid Res. 2006 June;47(6):1168–75.
42. Bose HS, Whittal RM, Ran Y, Bose M, Baker BY, Miller WL. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry. 2008 Feb 26;47(8):2277–88.
43. Letourneau D, Lorin A, Lefebvre A, Cabana J, Lavigne P, Lehoux JG. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5. Biochim Biophys Acta. 2013 July 16;1831(11):1589–99.
44. Letourneau D, Lorin A, Lefebvre A, Frappier V, Gaudreault F, Najmanovich R, et al. StAR-related lipid transfer domain protein 5 binds primary bile acids. J Lipid Res. 2012 Dec;53(12):2677–89.
45. Chen YC, Meier RK, Zheng S, Khundmiri SJ, Tseng MT, Lederer ED, et al. Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules. Am J Physiol Renal Physiol. 2009 Aug;297(2):F380–8.
46. Rodriguez-Agudo D, Calderon-Dominguez M, Medina MA, Ren S, Gil G, Pandak WM. ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J Lipid Res. 2012;53(12):2708–15.
47. Letourneau D, Lefebvre A, Frappier V, LeHoux JG, Lavigne P. Structure, dynamics and cholesterol binding site characterization of STARD6 from solution state NMR studies. Endocr Rev. 2012 June; 33, Meeting Abstracts, SUN-234(Meeting Abstracts).
48. Letourneau D, Lefebvre A, Lavigne P, LeHoux JG. STARD5 specific ligand binding: comparison with STARD1 and STARD4 subfamilies. Mol Cell Endocrinol. 2013 May 22;371 (1–2):20–5.
49. Chang IY, Kim JK, Lee SM, Kim JN, Soh J, Kim JW, et al. The changed immunoreactivity of StarD6 after pilocarpine-induced epilepsy. Neuroreport. 2009 July 1;20(10):963–7.
50. Chang IY, Shin SY, Kim JW, Yu JM, Kim JS, Song PI, et al. The changed immunolocalization of START-domain-containing 6 (StarD6) during the development of testes in rat perinatal hypothyroidism. Acta Histochem. 2007;109(4):315–21.
51. Gomes C, Oh SD, Kim JW, Chun SY, Lee K, Kwon HB, et al. Expression of the putative sterol binding protein Stard6 gene is male germ cell specific. Biol Reprod. 2005 March;72(3):651–8.
52. Chang IY, Jeon YJ, Jung SM, Jang YH, Ahn JB, Park KS, et al. Does the StarD6 mark the same as the StAR in the nervous system? J Chem Neuroanat. 2010 Nov;40(3):239–42.
53. Chang IY, Kim JH, Hwang G, Song PI, Song RJ, Kim JW, et al. Immunohistochemical detection of StarD6 in the rat nervous system. Neuroreport. 2007 Oct 8;18(15):1615–9.
54. Chang IY, Ohn T, Ko GS, Yoon Y, Kim JW, Yoon SP. Immunolocalization of steroidogenic acute regulatory protein-related lipid transfer (START) domain-containing proteins in the developing cerebellum of normal and hypothyroid rats. J Chem Neuroanat. 2012 Jan;43(1):28–33.
55. Tsutsui K. Biosynthesis, mode of action and functional significance of neurosteroids in the developing Purkinje cell. J Steroid Biochem Mol Biol. 2006 Dec;102(1–5):187–94.
56. Roderick SL, Chan WW, Agate DS, Olsen LR, Vetting MW, Rajashankar KR, et al. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat Struct Biol. 2002 July;9(7):507–11.
57. Flores-Martin J, Rena V, Angeletti S, Panzetta-Dutari GM, Genti-Raimondi S. The lipid transfer protein StarD7: structure, function, and regulation. Int J Mol Sci. 2013;14(3):6170–86.
58. Flores-Martin J, Rena V, Marquez S, Panzetta-Dutari GM, Genti-Raimondi S. StarD7 knockdown modulates ABCG2 expression, cell migration, proliferation, and differentiation of human choriocarcinoma JEG-3 cells. PLoS One. 2012;7(8):e44152.
59. Horibata Y, Sugimoto H. StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria. J Biol Chem. 2010 March 5;285(10):7358–65.
60. Ito M, Yamanashi Y, Toyoda Y, Izumi-Nakaseko H, Oda S, Sugiyama A, et al. Disruption of Stard10 gene alters the PPARalpha-mediated bile acid homeostasis. Biochim Biophys Acta. 2013 Feb;1831(2):459–68.
61. Olayioye MA, Vehring S, Muller P, Herrmann A, Schiller J, Thiele C, et al. StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein. J Biol Chem. 2005 July 22;280(29):27436–42.
62. Hanada K, Kumagai K, Tomishige N, Yamaji T. CERT-mediated trafficking of ceramide. Biochim Biophys Acta. 2009 July;1791(7):684–91.
63. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003 Dec 18;426(6968):803–9.
64. Kudo N, Kumagai K, Matsubara R, Kobayashi S, Hanada K, Wakatsuki S, et al. Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J Mol Biol. 2010 Feb 19;396(2):245–51.
65. Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, et al. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):488–93.
66. Kumagai K, Yasuda S, Okemoto K, Nishijima M, Kobayashi S, Hanada K. CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem. 2005 Feb 25;280(8):6488–95.
67. Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, et al. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem. 2003 March 21;278(12):10824–30.
68. Durkin ME, Ullmannova V, Guan M, Popescu NC. Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth. Oncogene. 2007 July 5;26(31):4580–9.
69. Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS, et al. DLC- 1: a Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med. 2007 Sept–Oct;11(5):1185–207.
70. Kawai K, Iwamae Y, Yamaga M, Kiyota M, Ishii H, Hirata H, et al. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells. 2009 Feb;14(2):227–41.
71. Kim TY, Healy KD, Der CJ, Sciaky N, Bang YJ, Juliano RL. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J Biol Chem. 2008 Nov 21;283(47):32762–70.
72. Kirkby B, Roman N, Kobe B, Kellie S, Forwood JK. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog Lipid Res. 2010 Oct;49(4):366–77.
73. Hunt MC, Yamada J, Maltais LJ, Wright MW, Podesta EJ, Alexson SE. A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. J Lipid Res. 2005 Sept;46(9):2029–32.
74. Kang HW, Niepel MW, Han S, Kawano Y, Cohen DE. Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism. FASEB J. 2012 May;26(5):2209–21.
75. Torres JZ, Summers MK, Peterson D, Brauer MJ, Lee J, Senese S, et al. The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly. Cell. 2011 Dec 9;147(6):1309–23.
76. Hoepfner S, Severin F, Cabezas A, Habermann B, Runge A, Gillooly D, et al. Modulation of receptor recycling and degradation by the endosomal kinesin KIF16B. Cell. 2005 May 6;121(3):437–50.
77. Miki H, Okada Y, Hirokawa N. Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol. 2005 Sept;15(9):467–76.
78. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, Yamazaki H, et al. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell. 1994 Dec 30;79(7):1209–20.
79. Romanowski MJ, Soccio RE, Breslow JL, Burley SK. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc Natl Acad Sci USA. 2002 May 14;99(10):6949–54.
80. Shindyalov IN, Bourne PE. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng. 1998 Sept;11(9):739–47.
81. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009 May 1;25(9):1189–91.
82. Yaworsky DC, Baker BY, Bose HS, Best KB, Jensen LB, Bell JD, et al. pH-dependent Interactions of the carboxyl-terminal helix of steroidogenic acute regulatory protein with synthetic membranes. J Biol Chem. 2005 Jan 21;280(3):2045–54.
83. Lorin A, Letourneau D, Lefebvre A, Lehoux JG, Lavigne P. (1)H, (13)C, and (15)N backbone chemical shift assignments of StAR-related lipid transfer domain protein 5 (STARD5). Biomol NMR Assign. 2012 March 6;7(1):21–4.
84. Stevens SY, Sanker S, Kent C, Zuiderweg ER. Delineation of the allosteric mechanism of a cytidylyltransferase exhibiting negative cooperativity. Nat Struct Biol. 2001 Nov;8(11): 947–52.
85. Barbar E, Lehoux JG, Lavigne P. Toward the NMR structure of StAR. Mol Cell Endocrinol. 2009 March 5;300(1–2):89–93.
86. Roostaee A, Barbar E, Lehoux JG, Lavigne P. Cholesterol binding is a prerequisite for the activity of the steroidogenic acute regulatory protein (StAR). Biochem J. 2008 June 15;412(3):553–62.
87. Roostaee A, Barbar E, Lavigne P, LeHoux JG. The mechanism of specific binding of free cholesterol by the steroidogenic acute regulatory protein: evidence for a role of the C-terminal alpha-helix in the gating of the binding site. Biosci Rep. 2009 April;29(2):89–101.
88. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta. 2009 July;1791(7):646–58.
89. Baker BY, Yaworsky DC, Miller WL. A pH-dependent molten globule transition is required for activity of the steroidogenic acute regulatory protein, StAR. J Biol Chem. 2005 Dec 16;280(50):41753–60.
90. Bose HS, Whittal RM, Baldwin MA, Miller WL. The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule. Proc Natl Acad Sci USA. 1999 June 22;96(13):7250–5.
91. Ptitsyn OB. Molten globule and protein folding. Adv Protein Chem. 1995;47:83–229.
92. White SH, Wimley WC. Hydrophobic interactions of peptides with membrane interfaces. Biochim Biophys Acta. 1998 Nov 10;1376(3):339–52.
93. Wimley WC, White SH. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol. 1996 Oct;3(10):842–8.
94. Lomize AL, Pogozheva ID, Lomize MA, Mosberg HI. The role of hydrophobic interactions in positioning of peripheral proteins in membranes. BMC Struct Biol. 2007;7:44.
95. Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 2012 Jan;40(Database issue):D370–6.